Today news
About the same in other media
Hedge funds dealt big losses as biotech stocks slump on moves to curb drug prices
Reading now: 409
fnlondon.comBiotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of Covid-19 vaccines, dealing big losses to some hedge funds.
The sector is being buffeted by concerns Congress will move to put a lid on drug pricing and a surfeit of early-stage biotech shares as the IPO market booms.
Perceptive...
Read more on fnlondon.comAbout this in other media
Cardano, Binance Coin, The Sandbox Price Analysis: 17 December ambcrypto.com /2 years ago
Crypto will become an inflation hedge in 2022, CME execs say fnlondon.com /2 years ago
Crypto will become an inflation hedge in 2022, CME execs say fnlondon.com /2 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
